Navigation Links
Albert Einstein College of Medicine Receives $25-Million Gift to Support Stem Cell and Epigenomic Research and Clinical Skills Training
Date:5/13/2008

s, epigenomics and clinical training were areas where we could help make an important contribution, both to Einstein and to the future of biomedical research," said Dr. Ruth Gottesman, who was elected chair of Einstein's Board of Overseers in 2007 and is the first woman, and the first former faculty member, to serve in that role. "We want our gift to support endeavors that will position Albert Einstein College of Medicine to excel in both research and medical education, while also attracting the best and brightest to our laboratories and to our classrooms."

"The Gottesman gift will contribute significantly to Einstein's already formidable research efforts in stem cell/regenerative medicine research and epigenomics," said Allen M. Spiegel, M.D., The Marilyn and Stanley M. Katz Dean at Einstein. "Additionally, the gift will establish an innovative facility to further enhance the training of future generations of physicians at Einstein, helping them master the clinical skills that will prepare them to be first-rate health care providers."

The specific benefits of the gift to Einstein, as well as to the patients who will be helped by the resulting research and training, are as follows:

-- Exploring the basic biology of stem cells -- discovering, for example,

how a human embryonic stem cell develops into a liver cell rather than

a brain cell -- is crucially important if stem cells are to be used to

treat a wide range of devastating human diseases. Einstein researchers

are at the forefront of this inquiry, and the Gottesman gift

establishing the Institute for Stem Cell and Regenerative Medicine

Research will help them achieve their research objectives.

Already, for example, Einstein professor Eric Bouhassira is well on the

way to directing human embryonic stem cells to form blood-forming cells

(which could save the lives of cancer patients needing transplants of'/>"/>

SOURCE The Albert Einstein College of Medicine of YeshivaUniversity
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
2. Transplanted cells may hold the key to curing hemophilia A, Einstein scientists report
3. World Debut for BSPs HyperQ Stress System: 57th Annual American College of Cardiology Meeting 2008
4. Boston College, MIT researchers achieve dramatic increase in thermoelectric efficiency
5. CV Therapeutics Announces Presentations at the American College of Cardiology 57th Annual Scientific Session
6. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
7. Logical Therapeutics Co-Founder and CEO Honored with a Distinguished Investigator Award from the American College of Critical Care Medicine
8. Results of Colon Cancer Study Utilizing Pressure Cycling Technology (PCT) Presented at the American College of Gastroenterology Annual Scientific Meeting
9. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
10. KGI and Smith College Establish Leadership Forum for Women in Bioscience
11. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Tenn. (PRWEB) December 23, 2014 Nashville ... was elected treasurer for the American Society for ... advancing knowledge and research in reproductive medicine. In ... a seat on the executive board and will have ... , Dr. Hill has actively supported ASRM since 1984 ...
(Date:12/24/2014)... -- PharmaBoardroom,s new report, , Healthcare ... for free download , digs deep into this vibrant ... the sector today. One area where ... developing a homegrown pharmaceutical manufacturing base, even if the government,s ... way off. A cursory comparison with neighboring Morocco ...
(Date:12/22/2014)... ROCKVILLE, Md. , Dec. 22, 2014 ... MKT: SYN), a developer of pathogen-specific therapies ... focus on protecting the microbiome, today announced ... a Phase 1a clinical trial of SYN-004, ... the prevention of Clostridium difficile (C. ...
(Date:12/22/2014)... December 22, 2014 The ... publication of original research, reviews and editorials addressing ... clinical practice, today published a provocative article exploring ... development, progression and potential treatment of prostate cancer. ... research and proposes the possibility that there could ...
Breaking Biology Technology:Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... Md., Oct. 28 Sirnaomics, Inc., (http://www.sirnaomics.com ... received an SBIR,(small business innovation research) grant ... Health (NIH). Sirnaomics, Inc., a,biopharmaceutical company founded ... interference (RNAi) Technology for novel targeted therapeutic,development. ...
... N30 Pharma (N30), a,biopharmaceutical company focused on ... nitric oxide bioavailability,announced today that it has completed ... N30 will use proceeds from this financing to ... its discovery and preclinical,research in the area of ...
... Achieves ... Collaboration Milestone, SAN DIEGO, CA - October 28, ... on using proprietary,technologies to discover and develop novel flavor ingredients for ... a payment from The Coca-Cola Company (NYSE: KO ) related ...
Cached Biology Technology:Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics 2Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics 3N30 Pharma Announces Financing, Expansion of Board 2SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 2SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 3
(Date:12/10/2014)... You,ve been here before: you desperately need to ... password, site key or the answer to your secret question. ... Today, Hoyos Labs , a digital ... finally put an end to the frustration that comes with ... 1U leverages a user,s smartphone to acquire his or her ...
(Date:12/10/2014)...  Wake Forest Baptist Medical Center today announced plans for ... Medicine. Funding for this $50 million capital project is ... publicly launched next summer. The medical ... series R.J. Reynolds Tobacco Company complex, adjacent to 525@vine ... with plans to be ready to welcome medical students ...
(Date:12/10/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ) ... Market in Japan 2014-2018" report to their ... The integration of biometrics and smart ... upgradation of the driver,s license is one of ... the aforementioned projects, biometrics is being used as ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... of clean green solar power may well hinge on ... the process by which green plants convert sunlight into ... Department of Energy (DOE),s Lawrence Berkeley National Laboratory (Berkeley ... recorded the first observation and characterization of a ...
... a team of researchers led by University of Notre ... in thinking about the genomics of speciation. Titled "Widespread ... today,s edition of the Proceedings of the National ... about how the genomes of newly forming species should ...
... ANN ARBOR, Mich. Researchers at the University ... radiation techniques for head and neck cancer to ... eating. A new study shows these principles and ... long-term swallowing complications. The researchers applied highly ...
Cached Biology News:Untangling the quantum entanglement behind photosynthesis 2Untangling the quantum entanglement behind photosynthesis 3Untangling the quantum entanglement behind photosynthesis 4Paper offers new insights into the genomics of speciation 2U-M study achieves reduced side effects in head and neck cancer treatment 2
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Mouse monoclonal [88B] to nicotinic Acetylcholine Receptor ( Abpromise for all tested applications)....
D4-GDI rabbit polyclonal antibody...
Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....
Biology Products: